The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer
Abstract
Small molecules targeting various aspects of the p53 protein pathway have shown significant promise in the treatment of a number of cancer types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a number of small molecule compounds, peptide or antibody drugs targeting p53 mutants have been developed to recover the native conformation or normal function of the p53 protein.381–385”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [382]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
Chiti, F., & Dobson, C. M. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045115 · Cited by 2,629
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551
The amyloid state and its association with protein misfolding diseases.
Knowles, T. P. J., Vendruscolo, M., & Dobson, C. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3810 · Cited by 2,382
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression
Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J., & Strasser, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.169 · Cited by 1,395
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
Haupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136
Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.
Karimian, A., Ahmadi, Y., & Yousefi, B. (2016) · DNA Repair · doi:10.1016/j.dnarep.2016.04.008 · Cited by 1,110
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
Bykov, V. J. N., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., Bergman, J., Wiman, K. G., & Selivanova, G. (2002) · Nature Medicine · doi:10.1038/nm0302-282 · Cited by 1,067
Targeting mutant p53 for efficient cancer therapy
Bykov, V. J. N., Eriksson, S. E., Bianchi, J., & Wiman, K. G. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.109 · Cited by 889
Prion-like transmission of protein aggregates in neurodegenerative diseases
Brundin, P., Melki, R., & Kopito, R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2873 · Cited by 778
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy
Tovar, C., Rosinski, J., Filipovic, Z., Higgins, B., Kolinsky, K., Hilton, H., Zhao, X., Vu, B. T., Qing, W., Packman, K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507493103 · Cited by 708
Ding, K., Lu, Y., Nikolovska-Coleska, Z., Wang, G., Qiu, S., Shangary, S., Gao, W., Qin, D., Stuckey, J., Krajewski, K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051122a · Cited by 702
Structure-based design of potent non-peptide MDM2 inhibitors
Ding, K., Lu, Y., Nikolovska-Coleska, Z., Qiu, S., Ding, Y., Gao, W., Stuckey, J., Krajewski, K., Roller, P. P., Tomita, Y., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051147z · Cited by 657
Schneekloth, A. R., Pucheault, M., Tae, H. S., & Crews, C. M. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.114 · Cited by 635
Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development
Ding, Q., Zhang, Z., Liu, J.-J., Jiang, N., Zhang, J., Ross, T. M., Chu, X.-J., Bartkovitz, D., Podlaski, F., Janson, C., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400487c · Cited by 595
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others
Sabapathy, K., & Lane, D. P. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.151 · Cited by 517
p21: a two-faced genome guardian.
Georgakilas, A. G., Martin, O. A., & Bonner, W. M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.02.001 · Cited by 489
Zhao, Y., Aguilar, A., Bernard, D., & Wang, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501092z · Cited by 462
Discovery of RG7112: a small-molecule MDM2 inhibitor in clinical development
Vu, B., Wovkulich, P., Pizzolato, G., Lovey, A., Ding, Q., Jiang, N., Liu, J.-J., Zhao, C., Glenn, K., Wen, Y., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4000657 · Cited by 395
p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation
Melino, G., Bernassola, F., Ranalli, M., Yee, K., Zong, W. X., Corazzari, M., Knight, R. A., Green, D. R., Thompson, C., & Vousden, K. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307469200 · Cited by 368
Hines, J., Lartigue, S., Dong, H., Qian, Y., & Crews, C. M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2918 · Cited by 348
A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
Soragni, A., Janzen, D. M., Johnson, L. M., Lindgren, A. G., Thai-Quynh Nguyen, A., Tiourin, E., Soriaga, A. B., Lu, J., Jiang, L., Faull, K. F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.002 · Cited by 341
Jin, C., & Reed, J. C. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm832 · Cited by 340
Wang, S., Sun, W., Zhao, Y., McEachern, D., Meaux, I., Barrière, C., Stuckey, J. A., Meagher, J. L., Bai, L., Liu, L., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0799 · Cited by 328
Li, Y., Yang, J., Aguilar, A., McEachern, D., Przybranowski, S., Liu, L., Yang, C.-Y., Wang, M., Han, X., & Wang, S. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00909 · Cited by 312
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
Zhang, Q., Bykov, V. J. N., Wiman, K. G., & Zawacka-Pankau, J. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0463-7 · Cited by 261
Holzer, P., Masuya, K., Furet, P., Kallen, J., Valat-Stachyra, T., Ferretti, S., Berghausen, J., Bouisset-Leonard, M., Buschmann, N., Pissot-Soldermann, C., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00810 · Cited by 203
Canon, J., Osgood, T., Olson, S. H., Saiki, A. Y., Robertson, R., Yu, D., Eksterowicz, J., Ye, Q., Jin, L., Chen, A., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0710 · Cited by 152
Discovery of a Small Molecule MDM2 Inhibitor (AMG 232) for Treating Cancer
Rew, Y., & Sun, D. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500627s · Cited by 125
A distinct p53 target gene set predicts for response to the selective p53–HDM2 inhibitor NVP-CGM097
Jeay, S., Gaulis, S., Ferretti, S., Bitter, H., Ito, M., Valat, T., Murakami, M., Ruetz, S., Guthy, D. A., Rynn, C., et al. (2015) · eLife · doi:10.7554/elife.06498 · Cited by 85
Rational Design and Binding Mode Duality of MDM2–p53 Inhibitors
Gonzalez-Lopez de Turiso, F., Sun, D., Rew, Y., Bartberger, M. D., Beck, H. P., Canon, J., Chen, A., Chow, D., Correll, T. L., Huang, X., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400293z · Cited by 82
Hiraki, M., Hwang, S.-Y., Cao, S., Ramadhar, T. R., Byun, S., Yoon, K. W., Lee, J. H., Chu, K., Gurkar, A. U., Kolev, V., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.07.016 · Cited by 81
Liao, G., Yang, D., Ma, L., Li, W., Hu, L., Zeng, L., Wu, P., Duan, L., & Liu, Z. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.044 · Cited by 63
The p53/MDM2/MDMX-targeted therapies – a clinical synopsis
Jiang, L., & Zawacka-Pankau, J. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2445-9 · Cited by 62
Cancer therapeutic targeting using mutant–p53-specific siRNAs
Ubby, I., Krueger, C., Rosato, R., Qian, W., Chang, J., & Sabapathy, K. (2019) · Oncogene · doi:10.1038/s41388-018-0652-y · Cited by 50
Research works printed but not linked: 197
- Hofseth, 2004, Trends Pharmacol. Sci., 25, 177, 10.1016/j.tips.2004.02.009 · DOI · Paper page
- Joerger, 2010, Cold Spring Harbor Perspect. Biol., 2, 1, 10.1101/cshperspect.a000919 · DOI · Paper page
- Chin, 2011, Nat. Med., 17, 297, 10.1038/nm.2323 · DOI · Paper page
- Lane, 1992, Nature, 358, 15, 10.1038/358015a0 · DOI · Paper page
- Joerger, 2016, Annu. Rev. Biochem., 85, 375, 10.1146/annurev-biochem-060815-014710 · DOI · Paper page
- Joerger, 2008, Annu. Rev. Biochem., 77, 557, 10.1146/annurev.biochem.77.060806.091238 · DOI · Paper page
- Jimenez, 1999, Oncogene, 18, 7656, 10.1038/sj.onc.1203013 · DOI · Paper page
- Meek, 2009, Cold Spring Harbor Perspect. Biol., 1, a000950, 10.1101/cshperspect.a000950 · DOI · Paper page
- Moll, 2003, Mol. Cancer Res., 1, 1001
- Wu, 1997, Mol. Med., 3, 441, 10.1007/BF03401691 · DOI · Paper page
- Levine, 1997, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
- Nag, 2013, J. Biomed. Res., 27, 254, 10.7555/JBR.27.20130030 · DOI · Paper page
- Friedman, 1993, Proc. Natl. Acad. Sci. U. S. A., 90, 3319, 10.1073/pnas.90.8.3319 · DOI · Paper page
- Brooks, 2010, Cell Res., 20, 614, 10.1038/cr.2010.53 · DOI · Paper page
- Chen, 2016, Cold Spring Harbor Perspect. Med., 6, a026104, 10.1101/cshperspect.a026104 · DOI · Paper page
- Helton, 2007, J. Cell. Biochem., 100, 883, 10.1002/jcb.21091 · DOI · Paper page
- Lukin, 2015, Mol. Cancer Res., 13, 16, 10.1158/1541-7786.MCR-14-0177 · DOI
- El-Deiry, 1993, Cell, 75, 817, 10.1016/0092-8674(93)90500-P · DOI · Paper page
- El-Deiry, 2016, Cancer Res., 76, 5189, 10.1158/0008-5472.CAN-16-2055 · DOI · Paper page
- Macleod, 1995, Genes Dev., 9, 935, 10.1101/gad.9.8.935 · DOI · Paper page
- Benson, 2014, Oncogene, 33, 3959, 10.1038/onc.2013.378 · DOI · Paper page
- Waldman, 1995, Cancer Res., 55, 5187
- Fischer, 2017, Oncogene, 36, 3943, 10.1038/onc.2016.502 · DOI · Paper page
- Kim, 2017, Cancer Res., 77, 3092, 10.1158/0008-5472.CAN-16-2098 · DOI · Paper page
- Rivlin, 2011, Genes Cancer, 2, 466, 10.1177/1947601911408889 · DOI · Paper page
- Silva, 2018, Acc. Chem. Res., 51, 181, 10.1021/acs.accounts.7b00473 · DOI
- Natan, 2011, J. Mol. Biol., 409, 358, 10.1016/j.jmb.2011.03.047 · DOI
- Baugh, 2018, Cell Death Differ., 25, 154, 10.1038/cdd.2017.180 · DOI · Paper page
- Freed-Pastor, 2012, Genes Dev., 26, 1268, 10.1101/gad.190678.112 · DOI · Paper page
- Joerger, 2007, Oncogene, 26, 2226, 10.1038/sj.onc.1210291 · DOI · Paper page
- Loh, 2010, Metallomics, 2, 442, 10.1039/c003915b · DOI
- Bullock, 1997, Proc. Natl. Acad. Sci. U. S. A., 94, 14338, 10.1073/pnas.94.26.14338 · DOI · Paper page
- Wilcken, 2012, J. Am. Chem. Soc., 134, 6810, 10.1021/ja301056a · DOI · Paper page
- Navalkar, 2019, Biochemistry, 146
- Xu, 2011, Nat. Chem. Biol., 7, 285, 10.1038/nchembio.546 · DOI · Paper page
- Kim, 2018, Cell Death Differ., 25, 161, 10.1038/cdd.2017.185 · DOI · Paper page
- Gaiddon, 2001, Mol. Cell. Biol., 21, 1874, 10.1128/MCB.21.5.1874-1887.2001 · DOI · Paper page
- Bo, 2014, Curr. Drug Targets, 15, 80, 10.2174/1389450114666140106101412 · DOI · Paper page
- Roth, 1996, Nat. Med., 2, 985, 10.1038/nm0996-985 · DOI · Paper page
- Olivier, 2009, Cancer Gene Ther., 16, 1, 10.1038/cgt.2008.69 · DOI · Paper page
- Speetjens, 2009, Clin. Cancer Res., 15, 1086, 10.1158/1078-0432.CCR-08-2227 · DOI · Paper page
- Yu, 2014, Apoptosis, 19, 1055, 10.1007/s10495-014-0990-3 · DOI · Paper page
- Momand, 1998, Nucleic Acids Res., 26, 3453, 10.1093/nar/26.15.3453 · DOI · Paper page
- Beloglazkina, 2020, Molecules, 25, 1211, 10.3390/molecules25051211 · DOI
- Murray, 2007, Pept. Sci., 88, 657, 10.1002/bip.20741 · DOI · Paper page
- Stoll, 2001, Biochemistry, 40, 336, 10.1021/bi000930v · DOI · Paper page
- Kumar, 2003, J. Med. Chem., 46, 2813, 10.1021/jm030213+ · DOI · Paper page
- Hsu, 2005, Planta Med., 71, 130, 10.1055/s-2005-837779 · doi:10.1055/s-2005-837779
- Silva, 2018, PLoS One, 13, e0202263, 10.1371/journal.pone.0202263 · DOI
- Vassilev, 2004, Science, 303, 844, 10.1126/science.1092472 · DOI · Paper page
- ElSawy, 2013, Cell Cycle, 12, 3727, 10.4161/cc.27273 · DOI
- Skalniak, 2018, Cancers, 10, 396, 10.3390/cancers10110396 · DOI
- Wang, 2011, Mol. Cancer Ther., 10, 69, 10.1158/1535-7163.MCT-10-0581 · DOI · Paper page
- Chopra, 2017, Oncotarget, 9, 6270, 10.18632/oncotarget.23569 · DOI
- Haupt, 2019, J. Mol. Cell Biol., 11, 231, 10.1093/jmcb/mjz007 · DOI
- Shadfan, 2012, Transl. Cancer Res., 1, 88
- Chang, 2013, Proc. Natl. Acad. Sci. U. S. A., 110, E3445, 10.1073/pnas.1303002110 · DOI · Paper page
- Benosman, 2007, Cell Death Differ., 14, 2047, 10.1038/sj.cdd.4402216 · DOI
- Lanni, 2012, Free Radicals Biol. Med., 52, 1727, 10.1016/j.freeradbiomed.2012.02.034 · DOI · Paper page
- Tisato, 2017, J. Hematol. Oncol., 10, 133, 10.1186/s13045-017-0500-5 · DOI · Paper page
- Gupta, 2016, Top. Curr. Chem., 375, 1
- Gollner, 2016, J. Med. Chem., 59, 10147, 10.1021/acs.jmedchem.6b00900 · DOI
- B. Yu and H.-M.Liu , The Development of New Spirooxindoles Targeting the p53–MDM2 Protein-Protein Interactions for Cancer Therapy , in Targeting Protein-Protein Interactions by Small Molecules , ed. C. Sheng and G. I. Georg , Springer Singapore , Singapore , 2018 , pp. 213–237
- Tolcher, 2019, Mol. Cancer Ther., 18, A086, 10.1158/1535-7163.TARG-19-A086 · DOI
- Barakat, 2019, Bioorg. Chem., 86, 598, 10.1016/j.bioorg.2019.01.053 · DOI
- Grasberger, 2005, J. Med. Chem., 48, 909, 10.1021/jm049137g · DOI · Paper page
- Parks, 2006, Bioorg. Med. Chem. Lett., 16, 3310, 10.1016/j.bmcl.2006.03.055 · DOI
- Koblish, 2006, Mol. Cancer Ther., 5, 160, 10.1158/1535-7163.MCT-05-0199 · DOI · Paper page
- Li, 2016, Bioorg. Med. Chem., 24, 1853, 10.1016/j.bmc.2016.03.010 · DOI
- Pei, 2007, J. Med. Chem., 50, 1983, 10.1021/jm061436d · DOI
- Tikhov, 2020, Org. Biomol. Chem., 18, 2793, 10.1039/D0OB00287A · DOI
- Yu, 2014, ACS Med. Chem. Lett., 5, 894, 10.1021/ml500142b · DOI
- Rew, 2012, J. Med. Chem., 55, 4936, 10.1021/jm300354j · DOI · Paper page
- Her, 2018, Cell Death Dis., 9, 792, 10.1038/s41419-018-0825-1 · DOI · Paper page
- Weisberg, 2015, Mol. Cancer Ther., 14, 2249, 10.1158/1535-7163.MCT-15-0429 · DOI · Paper page
- Gessier, 2015, Bioorg. Med. Chem. Lett., 25, 3621, 10.1016/j.bmcl.2015.06.058 · DOI
- Fang, 2020, Acta Pharm. Sin. B, 10.1016/j.apsb.2020.06.007 · DOI
- Rayan, 2017, PLoS One, 12, e0187925, 10.1371/journal.pone.0187925 · DOI · Paper page
- Qin, 2018, Genes Dis., 5, 204, 10.1016/j.gendis.2018.07.002 · DOI
- Qin, 2012, Curr. Med. Chem., 19, 5705, 10.2174/092986712803988910 · DOI
- Hsu, 2009, J. Agric. Food Chem., 57, 8688, 10.1021/jf901053x · DOI
- Chen, 2007, Eur. J. Pharmacol., 574, 94, 10.1016/j.ejphar.2007.07.028 · DOI
- Issaeva, 2004, Nat. Med., 10, 1321, 10.1038/nm1146 · DOI · Paper page
- Enge, 2009, Cancer Cell, 15, 171, 10.1016/j.ccr.2009.01.019 · DOI · Paper page
- Spinnler, 2011, Cell Death Differ., 18, 1736, 10.1038/cdd.2011.45 · DOI
- Dickinson, 2015, Front. Mol. Biosci., 2, 1, 10.3389/fmolb.2015.00039 · DOI
- Weilbacher, 2014, Cell Death Dis., 5, e1318, 10.1038/cddis.2014.284 · DOI
- Sanz, 2019, J. Mol. Cell Biol., 11, 586, 10.1093/jmcb/mjz075 · DOI
- Jiang, 2019, Cell Death Discovery, 5, 77, 10.1038/s41420-019-0157-7 · DOI
- Acedo, 2019, Future Sci. OA, 5, FSO366, 10.4155/fsoa-2018-0082 · DOI
- Paiva, 2019, Curr. Opin. Chem. Biol., 50, 111, 10.1016/j.cbpa.2019.02.022 · DOI · Paper page
- Pettersson, 2019, Drug Discovery Today: Technol., 31, 15, 10.1016/j.ddtec.2019.01.002 · DOI · Paper page
- Burslem, 2017, Chem. Rev., 117, 11269, 10.1021/acs.chemrev.7b00077 · DOI · Paper page
- Krenning, 2014, Mol. Cell, 55, 59, 10.1016/j.molcel.2014.05.007 · DOI · Paper page
- Burgess, 2016, Front. Oncol., 6, 1, 10.3389/fonc.2016.00007 · DOI · Paper page
- Hansen, 2018, J. Am. Chem. Soc., 140, 13136, 10.1021/jacs.8b04870 · DOI
- Blandino, 2018, J. Exp. Clin. Cancer Res., 37, 1, 10.1186/s13046-018-0705-7 · DOI · Paper page
- Ikari, 2019, Am. J. Pathol., 189, 784, 10.1016/j.ajpath.2018.12.015 · DOI
- Zawacka-Pankau, 2015, J. Intern. Med., 277, 248, 10.1111/joim.12336 · DOI · Paper page
- Parrales, 2015, Front. Oncol., 5, 1, 10.3389/fonc.2015.00288 · DOI · Paper page
- Li, 2019, Br. J. Pharmacol., 176, 817, 10.1111/bph.14572 · DOI
- Silva, 2020, Biomolecules, 10, 635, 10.3390/biom10040635 · DOI
- Loh, 2020, Biomolecules, 10, 303, 10.3390/biom10020303 · DOI
- Fra, 2017, Front. Mol. Neurosci., 10, 167, 10.3389/fnmol.2017.00167 · DOI
- Hallenbeck, 2017, Curr. Top. Med. Chem., 17, 4, 10.2174/1568026616666160719163839 · DOI
- Foster, 1999, Science, 286, 2507, 10.1126/science.286.5449.2507 · DOI · Paper page
- Zache, 2008, Mol. Oncol., 2, 70, 10.1016/j.molonc.2008.02.004 · DOI · Paper page
- Bykov, 2009, Cell Cycle, 8, 2509, 10.4161/cc.8.16.9382 · DOI
- Wassman, 2013, Nat. Commun., 4, 1407, 10.1038/ncomms2361 · DOI · Paper page
- Parrales, 2015, Front. Oncol., 5, 1, 10.3389/fonc.2015.00288 · DOI · Paper page
- Bykov, 2005, J. Biol. Chem., 280, 30384, 10.1074/jbc.M501664200 · DOI · Paper page
- Bou-Hanna, 2015, Cancer Lett., 359, 211, 10.1016/j.canlet.2015.01.014 · DOI
- Adams, 2012, Proc. Natl. Acad. Sci. U. S. A., 109, 15115, 10.1073/pnas.1212802109 · DOI · Paper page
- Raj, 2011, Nature, 475, 231, 10.1038/nature10167 · DOI · Paper page
- Pettit, 1989, Experientia, 45, 209, 10.1007/BF01954881 · DOI · Paper page
- Punganuru, 2016, Eur. J. Med. Chem., 107, 233, 10.1016/j.ejmech.2015.10.052 · DOI
- Kaar, 2010, Protein Sci., 19, 2267, 10.1002/pro.507 · DOI · Paper page
- Bauer, 2016, Proc. Natl. Acad. Sci. U. S. A., 113, e5271, 10.1073/pnas.1610421113 · DOI
- Bauer, 2019, Future Med. Chem., 11, 2491, 10.4155/fmc-2019-0181 · DOI
- Como, 1998, Oncogene, 16, 2527, 10.1038/sj.onc.1202041 · DOI · Paper page
- Boeckler, 2008, Proc. Natl. Acad. Sci. U. S. A., 105, 10360, 10.1073/pnas.0805326105 · DOI · Paper page
- Joerger, 2013, Nucleic Acids Res., 41, 6034, 10.1093/nar/gkt305 · DOI · Paper page
- Baud, 2018, Eur. J. Med. Chem., 152, 101, 10.1016/j.ejmech.2018.04.035 · DOI
- Bauer, 2020, ACS Chem. Biol., 15, 657, 10.1021/acschembio.9b00748 · DOI · Paper page
- Geschwind, 2015, Continuum, 21, 1612
- Eisenberg, 2017, Annu. Rev. Biochem., 86, 69, 10.1146/annurev-biochem-061516-045104 · DOI · Paper page
- DeToma, 2012, Chem. Soc. Rev., 41, 608, 10.1039/C1CS15112F · DOI · Paper page
- Eisenberg, 2012, Cell, 148, 1188, 10.1016/j.cell.2012.02.022 · DOI · Paper page
- Chen, 2010, Alzheimer's Dement., 6, e44, 10.1016/j.jalz.2010.08.135 · DOI
- Kim, 2020, J. Am. Chem. Soc., 142, 8183, 10.1021/jacs.9b13100 · DOI
- Hao, 2015, Curr. Protein Pept. Sci., 16, 135, 10.2174/1389203715666141128115649 · doi:10.2174/1389203715666141128115649
- Rangel, 2014, Prion, 8, 75, 10.4161/pri.27776 · DOI
- Ishimaru, 2003, Biochemistry, 42, 9022, 10.1021/bi034218k · DOI · Paper page
- Ano Bom, 2012, J. Biol. Chem., 287, 28152, 10.1074/jbc.M112.340638 · DOI · Paper page
- González de Aguilar, 2000, Neurobiol. Dis., 7, 406, 10.1006/nbdi.2000.0295 · DOI
- von Grabowiecki, 2016, eLife, 5, e10528, 10.7554/eLife.10528 · DOI
- Wang, 2015, Proc. Natl. Acad. Sci. U. S. A., 112, 2443, 10.1073/pnas.1500262112 · DOI · Paper page
- Costa, 2016, Cold Spring Harbor Perspect. Biol., 8, 1, 10.1101/cshperspect.a023614 · DOI
- Silva, 2014, Trends Biochem. Sci., 39, 260, 10.1016/j.tibs.2014.04.001 · DOI · Paper page
- Berman, 2017, npj Precis. Oncol., 1, 35, 10.1038/s41698-017-0038-6 · DOI · Paper page
- Ferraz da Costa, 2018, Oncotarget, 9, 29112, 10.18632/oncotarget.25631 · DOI
- Haque, 2018, Int. J. Biochem. Cell Biol., 96, 90, 10.1016/j.biocel.2018.01.014 · DOI
- Wilcken, 2012, Proc. Natl. Acad. Sci. U. S. A., 109, 13584, 10.1073/pnas.1211550109 · DOI · Paper page
- Wang, 2012, Proc. Natl. Acad. Sci. U. S. A., 109, 13590, 10.1073/pnas.1211557109 · DOI · Paper page
- Kravchenko, 2008, Proc. Natl. Acad. Sci. U. S. A., 105, 6302, 10.1073/pnas.0802091105 · DOI · Paper page
- Prabhu, 2016, Cancer Res., 76, 1989, 10.1158/0008-5472.CAN-14-2430 · DOI
- Hong, 2014, Cancer Res., 74, 1153, 10.1158/0008-5472.CAN-13-0955 · DOI
- Zhang, 2015, Cancer Res., 75, 3842, 10.1158/0008-5472.CAN-13-1079 · DOI
- Lu, 2008, Cancer Biol. Ther., 7, 2039, 10.4161/cbt.7.12.7461 · DOI
- Butler, 2006, Protein Sci., 15, 2457, 10.1110/ps.062324206 · DOI
- Blanden, 2015, Drug Discovery Today, 20, 1391, 10.1016/j.drudis.2015.07.006 · DOI
- Hainaut, 1993, Cancer Res., 53, 1739
- Puca, 2011, Cell Cycle, 10, 1679, 10.4161/cc.10.10.15642 · DOI
- Jayaraman, 2011, J. Nutr. Biochem., 22, 79, 10.1016/j.jnutbio.2009.12.001 · DOI
- Pucci, 2013, Dalton Trans., 42, 9679, 10.1039/c3dt50513h · DOI
- Garufi, 2013, J. Exp. Clin. Cancer Res., 32, 72, 10.1186/1756-9966-32-72 · DOI
- Blanden, 2015, Mol. Pharmacol., 87, 825, 10.1124/mol.114.097550 · DOI · Paper page
- Maret, 2017, Int. J. Mol. Sci., 18, 2285, 10.3390/ijms18112285 · DOI · Paper page
- Loh, 2010, Metallomics, 2, 442, 10.1039/c003915b · DOI
- Yu, 2014, Oncotarget, 5, 8879, 10.18632/oncotarget.2432 · DOI · Paper page
- Butler, 2003, Biochemistry, 42, 2396, 10.1021/bi026635n · DOI · Paper page
- Zaman, 2019, Mol. Cancer Ther., molcanther.1080.2018
- Yu, 2012, Cancer Cell, 21, 614, 10.1016/j.ccr.2012.03.042 · DOI · Paper page
- Yu, 2017, Mol. Pharmacol., 91, 567, 10.1124/mol.116.107409 · DOI · Paper page
- Kogan, 2016, Transl. Cancer Res., 5, 698, 10.21037/tcr.2016.11.74 · DOI
- Fernandes, 2017, J. Controlled Release, 245, 52, 10.1016/j.jconrel.2016.11.021 · DOI
- Silver, 2009, Neurotherapeutics, 6, 86, 10.1016/j.nurt.2008.10.034 · DOI
- Geldenhuys, 2011, Prog. Neurobiol., 94, 347, 10.1016/j.pneurobio.2011.04.010 · DOI
- Morphy, 2005, J. Med. Chem., 48, 6523, 10.1021/jm058225d · DOI · Paper page
- Jones, 2017, Chem. Sci., 8, 5636, 10.1039/C7SC01269A · DOI
- Fang, 2012, Neural Regener. Res., 7, 313
- Van der Schyf, 2009, Neurotherapeutics, 6, 1, 10.1016/j.nurt.2008.11.001 · doi:10.1016/j.nurt.2008.11.001
- Miller, 2018, Chem. – Eur. J., 24, 17734, 10.1002/chem.201802677 · DOI
- Stacy, 2016, J. Med. Chem., 59, 4965, 10.1021/acs.jmedchem.6b00238 · DOI · Paper page
- Miller, 2019, Chem. Sci., 10, 10802, 10.1039/C9SC04151F · DOI · Paper page
- Salim, 2016, Oncotarget, 7, 41363, 10.18632/oncotarget.9133 · DOI · Paper page
- Hemmings, 2012, Cold Spring Harbor Perspect. Biol., 4, a011189, 10.1101/cshperspect.a011189 · DOI · Paper page
- Maleki Vareki, 2018, PLoS One, 13, e0191766, 10.1371/journal.pone.0191766 · DOI
- Zhou, 2018, J. Mol. Cell Biol., 11, 293, 10.1093/jmcb/mjy072 · DOI · Paper page
- Peng, 2001, J. Biol. Chem., 276, 40583, 10.1074/jbc.M102817200 · DOI · Paper page
- Wang, 2003, J. Biol. Chem., 278, 2066, 10.1074/jbc.M206697200 · DOI
- Li, 2011, Mol. Cancer Res., 9, 577, 10.1158/1541-7786.MCR-10-0534 · DOI · Paper page
- Blagosklonny, 1995, Oncogene, 11, 933
- Blagosklonny, 1996, Proc. Natl. Acad. Sci. U. S. A., 93, 8379, 10.1073/pnas.93.16.8379 · DOI · Paper page
- Jhaveri, 2015, OncoTargets Ther., 8, 1849
- Alexandrova, 2015, Nature, 523, 352, 10.1038/nature14430 · DOI · Paper page
- Parrales, 2016, Nat. Cell Biol., 18, 1233, 10.1038/ncb3427 · DOI · Paper page
- Richardson, 2017, Cell Cycle, 16, 1719, 10.1080/15384101.2017.1356514 · DOI
- Hernandez-Borrero, 2018, Cell Cycle, 17, 557, 10.1080/15384101.2017.1346762 · DOI
- Gupta, 2014, Biochim. Biophys. Acta, Rev. Cancer, 1846, 405, 10.1016/j.bbcan.2014.08.003 · DOI · Paper page
- Schulz-Heddergott, 2018, Cancers, 10, 188, 10.3390/cancers10060188 · DOI
- Levy, 2011, Int. J. Biochem. Cell Biol., 43, 60, 10.1016/j.biocel.2010.10.017 · DOI · Paper page
- Ghosh, 2017, Cell Death Differ., 24, 1784, 10.1038/cdd.2017.105 · DOI
- Hientz, 2017, Oncotarget, 8, 8921, 10.18632/oncotarget.13475 · DOI · Paper page
- Zhou, 2019, J. Mol. Cell Biol., 11, 293, 10.1093/jmcb/mjy072 · DOI · Paper page
- Blandino, 1999, Oncogene, 18, 477, 10.1038/sj.onc.1202314 · DOI · Paper page
- Yang-Hartwich, 2015, Oncogene, 34, 3605, 10.1038/onc.2014.296 · DOI
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Metadata
- Authors
- Miller, J. J., Gaiddon, C., & Storr, T.
- Affiliations
- Department of Chemistry
- Inserm UMR_S 1113
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2020
- Volume
- 49
- Issue
- 19
- Pages
- 6995-7014
- ISSN
- 0306-0012
- 1460-4744
- Cited by
- 42
- References
- 41
- Language
- en
- Funders
- Natural Sciences and Engineering Research Council of Canada (201906749)
- Michael Smith Foundation for Health Research (Scholar Award)
- Simon Fraser University
- Centre National de la Recherche Scientifique
- Institut National de la Santé et de la Recherche Médicale
- Association pour la Recherche sur le Cancer
- Ligue Contre le Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.